All Stories

  1. Antonovsky’s sense of coherence and resistance resources reduce perception of burden in family carers of people with Alzheimer’s disease
  2. How well can electronic health records from primary care identify Alzheimer’s disease cases?
  3. Survival, effect measures, and impact numbers after dementia diagnosis: a matched cohort study
  4. Epidemiology of dementia: prevalence and incidence estimates using validated electronic health records from primary care
  5. A Path Analysis of Dependence and Quality of Life in Alzheimer’s Disease
  6. Consequences of Anosognosia on the Cost of Caregivers’ Care in Alzheimer’s Disease
  7. Diagnosis of Dementia in the Specialist Setting: A Comparison Between the Swedish Dementia Registry (SveDem) and the Registry of Dementias of Girona (ReDeGi)
  8. The Trail Making Test
  9. Course and Determinants of Anosognosia in Alzheimer’s Disease: A 12-Month Follow-up
  10. A path analysis of patient dependence and caregiver burden in Alzheimer's disease
  11. Gender differences in depression and pain: A two year follow-up study of the Survey of Health, Ageing and Retirement in Europe
  12. Adaptación y validación de la Frontotemporal Dementia Rating Scale (FTD-FRS) al castellano
  13. Prevalence and sociodemographic correlates of depressive and bipolar disorders in Catalonia (Spain) using DSM-5 criteria
  14. Clinical characteristics and course of dlb: Results from a large longitudinal multicentre cohort
  15. Pharmaceutical consumption and cost in patients with dementia: A longitudinal study by the Registry of Dementias of Girona (ReDeGi) in Catalonia (Spain)
  16. Risk of suicide: its occurrence and related variables among bereaved substance users
  17. Sense of Well-Being in Patients with Fibromyalgia: Aerobic Exercise Program in a Mature Forest—A Pilot Study
  18. Dependence Scale for Alzheimer’s Disease
  19. Rate of dementia diagnoses according to the degree of aging of the population
  20. Prevalencia de anosognosia en la enfermedad de Alzheimer
  21. Psychotropic Drugs in Patients With Alzheimer's Disease: A Longitudinal Study by the Registry of Dementias of Girona (ReDeGi) in Catalonia, Spain
  22. Abridged Scale for the Screening Anosognosia in Patients With Dementia
  23. Severity of Dementia, Anosognosia, and Depression in Relation to the Quality of Life of Patients with Alzheimer Disease: Discrepancies Between Patients and Caregivers
  24. Online Drawings for Dementia Diagnose: In-Air and Pressure Information Analysis
  25. Prevalencia de anticuerpos frente al virus de la hepatitis A en trabajadores del ámbito sanitario y variables asociadas
  26. Psychosis of Alzheimer Disease: Prevalence, Incidence, Persistence, Risk Factors, and Mortality
  27. Editorial
  28. Development of a multidimensional measure of fibromyalgia symptomatology: The comprehensive rating scale for fibromyalgia symptomatology
  29. Prevalence of chronic kidney disease in patients with type 2 diabetes in Spain: PERCEDIME2 study
  30. Factors Associated With the Variability in Caregiver Assessments of the Capacities of Patients With Alzheimer Disease
  31. Prevalence of chronic kidney disease in patients with type 2 diabetes in Spain: PERCEDIME2 study
  32. Pain treatment and its cost in old people with dementia: a descriptive analysis from the Registry of Dementias of Girona (ReDeGi)
  33. Demographically Adjusted Norms for Catalan Older Adultson the Stroop Color and Word Test
  34. A Preliminary Study of Online Drawings and Dementia Diagnose
  35. Evaluation of health-related quality of life in patients candidate for spine and other musculoskeletal surgery
  36. Drug use in patients with dementia: a register-based study in the health region of Girona (Catalonia/Spain)
  37. Psychosis of Alzheimer Disease
  38. Consumption of Pharmaceuticals in Primary Non-Alzheimer’s Degenerative Dementias
  39. Biometric Applications Related to Human Beings: There Is Life beyond Security
  40. Environmental Determinants of Quality of Life in Nursing Home Residents with Severe Dementia
  41. Hacia una evaluación de las capacidades instrumentales de los ancianos validada en nuestro entorno
  42. Use of Antidementia Drugs in Frontotemporal Lobar Degeneration
  43. Depression subtypes and 5-year risk of dementia and Alzheimer disease in patients aged 70 years
  44. Burden associated with the presence of anosognosia in Alzheimer's disease
  45. Why is cardiovascular risk stratification important in hypertensive patients?
  46. Prevalence of frailty phenotypes and risk of mortality in a community-dwelling elderly cohort
  47. Profile and variables related to antipsychotic consumption according to dementia subtypes
  48. Predictors of cognitive decline in Alzheimer's disease and mild cognitive impairment using the CAMCOG: a five-year follow-up
  49. Central Nervous System Drug Consumption Depending on the Time between Symptom Onset and the Diagnosis of Alzheimer’s Disease: An Analysis by the Registry of Dementias of Girona
  50. Medical, environmental and personal factors of disability in the elderly in Spain: a screening survey based on the International Classification of Functioning
  51. Percepción, actitudes y necesidades de los profesionales de atención primaria con relación al paciente con demencia
  52. Depression subtypes and 5-years risk of mortality in aged 70 years: a population-based cohort study
  53. Prevalence of disability in a composite ≥75 year-old population in Spain: A screening survey based on the International Classification of Functioning
  54. Differential features of burden between spouse and adult-child caregivers of patients with Alzheimer's disease: An exploratory comparative design
  55. Perfil de consumo farmacológico y función cognoscitiva en edad avanzada: estudio de población general no institucionalizada
  56. Incidence and subtypes of early-onset dementia in a geographically defined general population
  57. Syndromic Association of Behavioral and Psychological Symptoms of Dementia in Alzheimer Disease and Patient Classification
  58. Prevalencia de insuficiencia renal oculta y variables asociadas en una población de pacientes con diabetes tipo 2
  59. Cross-cultural adaptation and psychometric validation of a Spanish version of the Quality of Life in Late-Stage Dementia Scale
  60. Quality of Life of Patients with Alzheimer’s Disease: Differential Perceptions between Spouse and Adult Child Caregivers
  61. Drug consumption and cognitive function in non-institutionalized elderly: A population-based study
  62. Biopsychosocial differences between drivers and non-drivers over the age of 74
  63. Ejercicio físico y calidad de vida autopercibida en el anciano hipertenso
  64. Early window of mortality risk on 3xTgAD mice treated with an antipsychotic drug at advanced stages of the disease
  65. Factors related to perceived quality of life in patients with Alzheimer's disease: the patient's perception compared with that of caregivers
  66. Prevalence and Risk Factors of Suspected Elder Abuse Subtypes in People Aged 75 and Older
  67. A clinical registry of dementia based on the principle of epidemiological surveillance
  68. Trazodone for Alzheimer's disease: A naturalistic follow-up study
  69. Adaptación y validez convergente de una versión telefónica del Mini-Mental State Examination
  70. Conducción de vehículos a motor y deterioro cognitivo en mayores de 74 años
  71. Mortality after a Diagnosis of Dementia in a Population Aged 75 and Over in Spain
  72. Demencia. Concepto. Clasificaci?n. Epidemiolog?a. Aspectos socioecon?micos
  73. Reply
  74. Comparison of Different Clinical Diagnostic Criteria for Depression in Alzheimer Disease
  75. Factores asociados a la mortalidad en pacientes con enfermedad de Alzheimer tratados con galantamina
  76. Differential Efficacy of Treatment with Acetylcholinesterase Inhibitors in Patients with Mild and Moderate Alzheimer’s Disease over a 6-Month Period
  77. Affective Disorders in Alzheimer Disease
  78. Análisis de los costes de la enfermedad de Alzheimer en función del deterioro cognitivo y funcional
  79. Neuropsychological profile of Alzheimer?s disease in women: moderate and moderately severe cognitive decline
  80. Analysis of Self-Concept in Older Adults in Different Contexts
  81. Incidence of Dementia in a Rural Community in Spain: The Girona Cohort Study
  82. Análisis de los costes de la enfermedad de Alzheimer en función del deterioro cognitivo y funcional
  83. Evolution of Depressive Symptoms in Alzheimer Disease
  84. Abridged Anosognosia Questionnaire—Dementia
  85. Comprehensive Rating Scale for Fibromyalgia Symptomatology